Pathways Knowlegdes

Necessitatibus eius consequatur ex aliquid fuga eum quidem sint consectetur velit

Pathway DOIs Note
Lidocaine metabolism

Accession ID: WikiPathways:WP3254
  • 10.1016/j.clpt.2003.09.007
 Orlando R, Piccoli P, De Martin S, Padrini R, Floreani M, Palatini P. Cytochrome P450 1A2 is a major determinant of lidocaine metabolism in vivo: Effects of liver function. Clinical Pharmacology & Therapeutics. 2004 Jan 22;75(1):80–8. doi: 10.1016/j.clpt.2003.09.007.
Lidocaine metabolism

Accession ID: WikiPathways:WP2646
  • 10.1111/j.1742-7843.2006.pto_482.x
 Isohanni MH, Neuvonen PJ, Olkkola KT. Effect of fluvoxamine and erythromycin on the pharmacokinetics of oral lidocaine. Basic Clin Pharmacol Toxicol. 2006 Aug;99(2):168–72. doi: 10.1111/j.1742-7843.2006.pto_482.x. PMID: 16918719.
Lidocaine (Local Anaesthetic) Action Pathway

Accession ID: PathBank:SMP0000398		 -
Lidocaine (Local Anaesthetic) Metabolism Pathway

Accession ID: PathBank:SMP0000620		 -
Lidocaine (Antiarrhythmic) Action Pathway

Accession ID: PathBank:SMP0000328		 -